About COVID-RED

COVID-RED is a project that is part of the EU Innovative Medicines Initivative and will evaluate the use and performance of a CE-marked device (wearable), which uses sensors to measure breathing rate, pulse rate, skin temperature, and heart rate variability for the purpose of early detection and monitoring of COVID-19 in general and high-risk populations. At the same time, a mobile application will be used to track participant-reported symptoms.
READ MORE >>

NEWS

LEES MEER
Verdwenen data in de app
Apr
21
2021
Lees meer >
LEES MEER
Pilot studie COVID-RED
Apr
09
2021
Lees meer >

Twitter

Is this you?
✅ Want to contribute to research to stop #COVID19
✅ Into #DigitalHealth tech
✅ Based in 🇳🇱
Sign up for our @CovidRed project's study on how digital tech could detect COVID infection before people feel ill!
Info: http://bit.ly/2Qe3zaa
#UnitedAgainstCoronavirus

De COVI-GAPP studie heeft aangetoond dat de @AvaWomen armband, welke wordt onderzocht in het @CovidRed onderzoek, in 71% van de gevallen een COVID-19 infectie detecteert voordat de eerste symptomen optraden. Meer weten? Ga naar https://www.covid-red.eu/deelnemen

Instagram

COVID-RED

Uw hulp in de strijd tegen corona

The COVID-RED consortium

The COVID-RED consortium brings together nine organisations from four countries with the aim to deliver a large body of information on COVID-19 monitoring that can be used to develop additional diagnostics and therapeutics in addition to validating remote vital signs and self-reported symptoms monitoring systems.

OUR CONSORTIUM
»

The COVID-RED project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101005177. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA.